Application and limitations of chloromethyl-benzamidodialkylcarbocyanine for tracing cells used in bone tissue engineering

被引:41
作者
Kruyt, MC [1 ]
De Bruijn, J
Veenhof, M
Oner, FC
Van Blitterswijk, CA
Verbout, AJ
Dhert, WJA
机构
[1] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands
[2] IsoTis, Bilthoven, Netherlands
[3] Univ Twente, Twente, Netherlands
来源
TISSUE ENGINEERING | 2003年 / 9卷 / 01期
关键词
D O I
10.1089/107632703762687582
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bone tissue engineering has the potential to provide us with an autologous bone substitute. Despite extensive research to optimize the technique, little is known about the survival and function of the cells after implantation. To monitor the cells, in vivo labeling is the method of choice. In this study we investigated the use of the fluorescent membrane marker chloromethyl-benzamidodialkylcarbocyanine (CM-Dil) to label cells used in bone tissue engineering. When applying label concentrations up to 50 muM, cells could be labeled efficiently without negative effects on cell vitality, proliferation, or bone-forming capacity. Porous hydroxyapatite scaffolds were seeded with labeled cells, and up to 6 weeks after implantation in nude mice cells could be traced inside tissue-engineered bone. However, contrary to other reports concerning intramembranous labels, transfer of the label from labeled to unlabeled cells was detected. Transfer occurred both in vitro and in vivo between vital cells and between dead and living cells. To determine when in vivo label transfer happened, devitalized, labeled constructs were implanted for various time periods in nude mice. The presence of vital labeled cells inside these constructs, when evaluated at different implantation periods, indicated transfer of the label. Transfer occurred at 7 days postimplantation when 40 muM label was applied, whereas 10 muM labeled constructs showed transfer 10 days after implantation. These findings indicate that CM-Dil label is useful for in vivo tracing of cells for follow-up periods up to 10 days. This makes the label particularly useful for cell survival studies in tissue-engineered implants.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 36 条
[1]   LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors [J].
Allay, JA ;
Dennis, JE ;
Haynesworth, SE ;
Majumdar, MK ;
Clapp, DW ;
Shultz, LD ;
Caplan, AI ;
Gerson, SL .
HUMAN GENE THERAPY, 1997, 8 (12) :1417-1427
[2]   The relationship of blood lymphocytes to the recirculating lymphocyte pool [J].
Andrade, WN ;
Johnston, MG ;
Hay, JB .
BLOOD, 1998, 91 (05) :1653-1661
[3]   Association of porous hydroxyapatite and bone marrow cells for bone regeneration [J].
Anselme, K ;
Noël, B ;
Flautre, B ;
Blary, MC ;
Delecourt, C ;
Descamps, M ;
Hardouin, P .
BONE, 1999, 25 (02) :51S-54S
[4]   A NOVEL-APPROACH TO THE MEASUREMENT OF DIFFERENT IN-VITRO LEUKEMIC-CELL GROWTH-PARAMETERS - THE USE OF PKH GL FLUORESCENT-PROBES [J].
ASHLEY, DM ;
BOL, SJ ;
WAUGH, C ;
KANNOURAKIS, G .
LEUKEMIA RESEARCH, 1993, 17 (10) :873-882
[5]   Viability of fibroblast-seeded ligament analogs after autogenous implantation [J].
Bellincampi, LD ;
Closkey, RF ;
Prasad, R ;
Zawadsky, JP ;
Dunn, MG .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (04) :414-420
[6]   The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects [J].
Bruder, SP ;
Kraus, KH ;
Goldberg, VM ;
Kadiyala, S .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (07) :985-996
[7]  
BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
[8]   Autologous bone grafting in staged scoliosis surgery - The patient as bone bank [J].
Chugh, S ;
Marks, DS ;
Mangham, DC ;
Thompson, AG .
SPINE, 1998, 23 (16) :1793-1795
[9]   How severe must repetitive loading be to kill chondrocytes in articular cartilage? [J].
Clements, KM ;
Bee, ZC ;
Crossingham, GV ;
Adams, MA ;
Sharif, M .
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (05) :499-507
[10]  
Decker S, 1979, Z Plast Chir, V3, P159